Current treatment practices for anemia in patients with chronic kidney disease and future opportunities with hypoxia-inducible factor prolyl hydroxylase inhibitors: a narrative review

被引：0
|
作者：
Mercedes Kile
Patcharaporn Sudchada
机构：
[1] University of Wisconsin-Madison,School of Pharmacy
[2] Naresuan University,Faculty of Pharmaceutical Sciences
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; Anemia; Iron; ESA; Hypoxia-inducible factor prolyl hydroxylase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 290
页数：7
相关论文
共 50 条
  • [31] Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
    Locatelli, Francesco
    Fishbane, Steven
    Block, Geoffrey A.
    Macdougall, Iain C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (03) : 187 - 199
  • [32] Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
    Tian, Lei
    Wang, Mengdi
    Liu, Mengchao
    Pang, Yanyu
    Zhao, Jingwen
    Zheng, Bingjie
    Wang, Yutong
    Zhao, Wenjing
    RENAL FAILURE, 2024, 46 (01)
  • [33] A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease
    Chen, Jun
    Shou, Xinyang
    Xu, Yanyan
    Jin, Lie
    Zhu, Chaoyong
    Ye, Xiaolan
    Mei, Ziwei
    Chen, Peipei
    AGING-US, 2023, 15 (06): : 2237 - 2274
  • [34] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Renal Anemia: A Meta-Analysis of Randomized Trials
    Wen, Tong
    Zhang, Xinzhou
    Wang, Zhen
    Zhou, Ru
    NEPHRON, 2020, 144 (11) : 572 - 582
  • [35] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in Non-Dialysis Dependent Chronic Kidney Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Tyagi, Jyoti
    Kaur, Manveen
    Moola, Sandeep
    Ramachandran, Raja
    Meena, Priti
    Bajpai, Divya
    Bhaumik, Soumyadeep
    INDIAN JOURNAL OF NEPHROLOGY, 2025, 35 (02) : 217 - 233
  • [36] Prolyl-hydroxylase inhibitors for the treatment of anemia in chronic kidney disease
    McMahon, Gearoid M.
    Singh, Ajay K.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06) : 600 - 606
  • [37] Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
    Kaplan, Joshua M.
    Sharma, Neeraj
    Dikdan, Sean
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [38] An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease
    Zhao, Hanxue
    Li, Peiyun
    Zhang, Hong-Liang
    Jia, Linpei
    RENAL FAILURE, 2023, 45 (02)
  • [39] Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
    Hasegawa, Sho
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (05) : 331 - 338
  • [40] The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors
    Locatelli, Francesco
    Del Vecchio, Lucia
    Elliott, Steve
    CLINICAL KIDNEY JOURNAL, 2023, 16 (10) : 1563 - 1579
12345